Summary | Amid accusations the drug maker misled investors and
patients about the safety of its drug, Orexigen Therapeutics is
now feuding with Takeda Pharmaceutical, its marketing partner,
over the cost of a clinical trial that was required by the FDA.
patients about the safety of its drug, Orexigen Therapeutics is
now feuding with Takeda Pharmaceutical, its marketing partner,
over the cost of a clinical trial that was required by the FDA.
blogs.wsj.com | 13 May 2015